About the Authors
- Niaina Rakotosamimanana
-
Affiliation Unité des Mycobactéries, Institut Pasteur de Madagascar, Antananarivo, Madagascar
- T. Mark Doherty
-
Current address: GlaxoSmithKline, Copenhagen, Denmark
Affiliation Staten Serum Institut, Copenhagen, Denmark
- Lova H. Andriamihantasoa
-
Affiliation Unité des Mycobactéries, Institut Pasteur de Madagascar, Antananarivo, Madagascar
- Vincent Richard
-
Current address: Unité d'épidémiologie, Institut Pasteur de Dakar, Dakar, Sénégal
Affiliation Unité d'épidémiologie, Institut Pasteur de Madagascar, Antananarivo, Madagascar
- Brigitte Gicquel
-
Affiliation Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France
- Jean-Louis Soares
-
Affiliation Unité d'épidémiologie, Institut Pasteur de Madagascar, Antananarivo, Madagascar
- Alimuddin Zumla
-
Affiliation Division of Infection and Immunity, University College London, London, United Kingdom
- Voahangy Rasolofo Razanamparany
-
* E-mail: vrasolof@pasteur.mg
Affiliation Unité des Mycobactéries, Institut Pasteur de Madagascar, Antananarivo, Madagascar
Competing Interests
One of the authors (TMD) is now employed by GlaxoSmithKline as an adviser on vaccination. The work described in this manuscript was completed prior to his current employment, and GlaxoSmithKline has had no input into the study design, execution, or analysis, or the writing of the manuscript. Prof. TMD holds no shares, patents or grants in GlaxoSmithKline or other companies involved in TB research or treatment, and therefore has no identified conflicts of interest. TMD is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: TMD JLS BG AZ VRR. Performed the experiments: NR LHA. Analyzed the data: NR VR VRR TMD. Contributed reagents/materials/analysis tools: BG TMD AZ VRR. Wrote the paper: NR TMD AZ VRR. Obtained the VACSIS grant: AZ. Grant co-PI: TMD. Madagascar grant holder and coordinated the study: VRR.